Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Headline"

26 News Found

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials
News | June 09, 2026

Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials

Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy


AstraZeneca to showcase cancer pipeline push at ASCO 2026
R&D | May 25, 2026

AstraZeneca to showcase cancer pipeline push at ASCO 2026

Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies


Dyno unveils next-gen AI-designed gene delivery capsids targeting brain & muscle
News | May 19, 2026

Dyno unveils next-gen AI-designed gene delivery capsids targeting brain & muscle

This positions its platform as a rapidly evolving engine for next-generation genetic medicine


JB Chemicals reports muted Q4 FY26 as integration resets business
News | May 12, 2026

JB Chemicals reports muted Q4 FY26 as integration resets business

The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year


Lonza surges on biologics boom
News | May 09, 2026

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals


Moderna posts Q1 2026 loss despite revenue surge
News | May 04, 2026

Moderna posts Q1 2026 loss despite revenue surge

Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets